Furui Medical released its 2026 interim report on August 25, 2026. Total operating revenue was 755 million yuan, net profit attributable to the parent company was 63.9404 million yuan, and net cash inflow from operating activities was 176 million yuan. The latest asset-liability ratio was 28.30 percent, up 0.81 percentage points from the previous quarter. The latest gross margin was 75.76 percent, the latest return on equity was 3.25 percent, and diluted earnings per share was 0.24 yuan. The latest total asset turnover was 0.22 times, down 4.75 percent from the same period last year, and the latest inventory turnover was 1.24 times. The number of shareholders was 24,000, and the top ten shareholders held 83.9079 million shares, accounting for 31.78 percent of total share capital.
Inner Mongolia Furui Med SciInterim report shows net profit and revenue, but no comparative expectations or market reaction; impact unclear.
